TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
96.44
-0.64 (-0.66%)
May 5, 2026, 10:15 AM EDT - Market open

TransMedics Group Revenue

In the year 2025, TransMedics Group had annual revenue of $605.49M with 37.13% growth. TransMedics Group had revenue of $160.76M in the quarter ending December 31, 2025, with 32.18% growth.

Revenue (ttm)
$605.49M
Revenue Growth
+37.13%
P/S Ratio
5.45
Revenue / Employee
$674,269
Employees
898
Market Cap
3.33B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025605.49M163.95M37.13%
Dec 31, 2024441.54M199.92M82.74%
Dec 31, 2023241.62M148.16M158.53%
Dec 31, 202293.46M63.20M208.83%
Dec 31, 202130.26M4.62M18.03%
Dec 31, 202025.64M2.04M8.62%
Dec 28, 201923.60M10.59M81.33%
Dec 29, 201813.02M5.33M69.38%
Dec 30, 20177.69M-5.33M-40.96%
Dec 31, 201613.02M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Bruker3.44B
AdaptHealth3.24B
Integer Holdings1.86B
LivaNova1.39B
Haemonetics1.32B
Neogen870.56M
iRhythm Holdings787.85M
NovoCure674.41M
Revenue Rankings